Stock Track | Organon & Co Soars 14.92% in Pre-market on $11.75 Billion Acquisition by Sun Pharma

Stock Track

Apr 27

Organon & Co's stock surged 14.92% in pre-market trading following the announcement of a definitive agreement to be acquired by Sun Pharmaceutical Industries.

The sharp rise was driven by news that Sun Pharma will acquire Organon in an all-cash transaction valued at approximately $11.75 billion. Under the terms of the agreement, Organon shareholders will receive $14.00 per share in cash, representing a significant premium to recent trading prices.

The acquisition is expected to enhance Sun Pharma's global footprint, particularly in women's health and biosimilars, while creating a combined entity with projected revenues of about $12.4 billion. The transaction has been approved by the boards of both companies and is anticipated to close in early 2027, subject to regulatory approvals and Organon stockholder consent.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1156341895"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156341895\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156341895?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-27 16:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156341895","market":"nz","top_or_hot":-1,"title":"Stock Track | Organon & Co Soars 14.92% in Pre-market on $11.75 Billion Acquisition by Sun Pharma","media":"Stock Track","content":"<p>Organon & Co's stock surged 14.92% in pre-market trading following the announcement of a definitive agreement to be acquired by Sun Pharmaceutical Industries.</p><p>The sharp rise was driven by news that Sun Pharma will acquire Organon in an all-cash transaction valued at approximately $11.75 billion. Under the terms of the agreement, Organon shareholders will receive $14.00 per share in cash, representing a significant premium to recent trading prices.</p><p>The acquisition is expected to enhance Sun Pharma's global footprint, particularly in women's health and biosimilars, while creating a combined entity with projected revenues of about $12.4 billion. The transaction has been approved by the boards of both companies and is anticipated to close in early 2027, subject to regulatory approvals and Organon stockholder consent.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Organon & Co Soars 14.92% in Pre-market on $11.75 Billion Acquisition by Sun Pharma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Organon & Co Soars 14.92% in Pre-market on $11.75 Billion Acquisition by Sun Pharma\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-27 16:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Organon & Co's stock surged 14.92% in pre-market trading following the announcement of a definitive agreement to be acquired by Sun Pharmaceutical Industries.</p><p>The sharp rise was driven by news that Sun Pharma will acquire Organon in an all-cash transaction valued at approximately $11.75 billion. Under the terms of the agreement, Organon shareholders will receive $14.00 per share in cash, representing a significant premium to recent trading prices.</p><p>The acquisition is expected to enhance Sun Pharma's global footprint, particularly in women's health and biosimilars, while creating a combined entity with projected revenues of about $12.4 billion. The transaction has been approved by the boards of both companies and is anticipated to close in early 2027, subject to regulatory approvals and Organon stockholder consent.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OGN","symbol_name":"Organon & Co","start_time":0,"source_url":"","article_id":"1156341895","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156341895","pubTimestamp":1777277102,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Organon & Co's stock surged 14.92% in pre-market trading following the announcement of a definitive agreement to be acquired by Sun Pharmaceutical Industries.The sharp rise was driven by news that...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OGN":"Organon & Co"},"translate_title":"个股追踪|Organon&Co被Sun Pharma 117.5亿美元收购盘前大涨14.92%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OGN":1},"content_text":"Organon & Co's stock surged 14.92% in pre-market trading following the announcement of a definitive agreement to be acquired by Sun Pharmaceutical Industries.The sharp rise was driven by news that Sun Pharma will acquire Organon in an all-cash transaction valued at approximately $11.75 billion. Under the terms of the agreement, Organon shareholders will receive $14.00 per share in cash, representing a significant premium to recent trading prices.The acquisition is expected to enhance Sun Pharma's global footprint, particularly in women's health and biosimilars, while creating a combined entity with projected revenues of about $12.4 billion. The transaction has been approved by the boards of both companies and is anticipated to close in early 2027, subject to regulatory approvals and Organon stockholder consent.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}